| High prevalence of anaphylaxis in patients with systemic mastocytosis–a single‐centre experience T Gülen, H Hägglund, B Dahlen, G Nilsson Clinical & Experimental Allergy 44 (1), 121-129, 2014 | 178 | 2014 |
| Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease T Gülen, H Hägglund, B Dahlén, G Nilsson Journal of internal medicine 279 (3), 211-228, 2016 | 95 | 2016 |
| Allergies and COVID‐19 vaccines: an ENDA/EAACI position paper A Barbaud, LH Garvey, A Arcolaci, K Brockow, F Mori, C Mayorga, ... Allergy 77 (8), 2292-2312, 2022 | 85 | 2022 |
| Risk factor analysis of anaphylactic reactions in patients with systemic mastocytosis T Gülen, C Ljung, G Nilsson, C Akin The Journal of Allergy and Clinical Immunology: In Practice 5 (5), 1248-1255, 2017 | 83 | 2017 |
| The presence of mast cell clonality in patients with unexplained anaphylaxis T Gülen, H Hägglund, B Sander, B Dahlén, G Nilsson Clinical & Experimental Allergy 44 (9), 1179-1187, 2014 | 79 | 2014 |
| Fc gamma RIIIB polymorphism: evidence that NA1/NA2 and SH are located in two closely linked loci and that the SH allele is linked to the NA1 allele in the Danish population R Steffensen, T Gulen, K Varming, J C Transfusion 39 (6), 593-598, 1999 | 70 | 1999 |
| Global classification of mast cell activation disorders: an ICD-10-CM–adjusted proposal of the ECNM-AIM consortium P Valent, K Hartmann, P Bonadonna, T Gülen, K Brockow, ... The Journal of Allergy and Clinical Immunology: In Practice 10 (8), 1941-1950, 2022 | 54 | 2022 |
| Multidisciplinary management of mastocytosis: nordic expert group consensus S Broesby-Olsen, I Dybedal, T Gülen, TK Kristensen, MB Møller, ... Acta dermato-venereologica 96 (5), 602-614, 2016 | 47 | 2016 |
| COVID-19 vaccination in mastocytosis: recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM) P Bonadonna, K Brockow, M Niedoszytko, HO Elberink, C Akin, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (6), 2139-2144, 2021 | 45 | 2021 |
| Selecting the right criteria and proper classification to diagnose mast cell activation syndromes: a critical review T Gülen, C Akin, P Bonadonna, F Siebenhaar, S Broesby-Olsen, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (11), 3918-3928, 2021 | 44 | 2021 |
| European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives. P Valent, M Arock, P Bonadonna, K Brockow, S Broesby-Olsen, ... Wiener klinische Wochenschrift 124, 2012 | 41 | 2012 |
| Venom immunotherapy in patients with clonal mast cell disorders: IgG4 correlates with protection J Jarkvist, C Salehi, C Akin, T Gülen Allergy 75 (1), 169-177, 2020 | 38 | 2020 |
| Anaphylaxis and mast cell disorders T Gülen, C Akin Immunology and Allergy Clinics 42 (1), 45-63, 2022 | 34 | 2022 |
| Low frequency of IgE-mediated food hypersensitivity in mastocytosis J Jarkvist, K Brockow, T Gülen The Journal of Allergy and Clinical Immunology: In Practice 8 (9), 3093-3101, 2020 | 32 | 2020 |
| Idiopathic anaphylaxis: a perplexing diagnostic challenge for allergists T Gulen, C Akin Current Allergy and Asthma Reports 21, 1-10, 2021 | 27 | 2021 |
| Flushing, fatigue, and recurrent anaphylaxis: a delayed diagnosis of mastocytosis T Gülen, H Hägglund, SE Dahlén, B Sander, B Dahlén, G Nilsson The Lancet 383 (9928), 1608, 2014 | 27 | 2014 |
| Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry VE Kennedy, C Perkins, A Reiter, M Jawhar, J Lübke, HC Kluin-Nelemans, ... Blood advances 7 (9), 1713-1724, 2023 | 26 | 2023 |
| Pharmacotherapy of mast cell disorders T Gülen, C Akin Current Opinion in Allergy and Clinical Immunology 17 (4), 295-303, 2017 | 24 | 2017 |
| Assessment of in vivo mast cell reactivity in patients with systemic mastocytosis T Gülen, C Möller Westerberg, K Lyberg, M Ekoff, J Kolmert, J Bood, ... Clinical & Experimental Allergy 47 (7), 909-917, 2017 | 23 | 2017 |
| The normal range of baseline tryptase should be 1-15 ng/ml and covers healthy individuals with hereditary alpha tryptasemia P Valent, G Hoermann, P Bonadonna, K Hartmann, WR Sperr, ... The Journal of Allergy and Clinical Immunology: In Practice, 2023 | 22 | 2023 |
Gunnar NilssonKarolinska InstitutetVerified email at ki.se
